News
TMDX
136.34
+0.95%
1.28
TransMedics: Robust Early 2026 Demand and DCD Leadership Underpin Buy Rating and Revenue Growth Outlook
TipRanks · 27m ago
TransMedics receives FDA IDE approval for OCS ENHANCE Heart trial
TipRanks · 23h ago
TransMedics erhält vollständige FDA-IDE-Zulassung für OCS Heart ENHANCE Trial
Reuters · 23h ago
TRANSMEDICS RECEIVES FULL AND UNCONDITIONAL FDA IDE APPROVAL FOR NEXT-GENERATION OCS HEART ENHANCE TRIAL
Reuters · 23h ago
Weekly Report: what happened at TMDX last week (0202-0206)?
Weekly Report · 1d ago
TransMedics management to meet virtually with Seaport Research
TipRanks · 1d ago
TD Cowen Sticks to Its Buy Rating for TransMedics Group (TMDX)
TipRanks · 4d ago
TransMedics Group Names New Commercial Leader
TipRanks · 5d ago
Commit To Buy TransMedics Group At $80, Earn 16.2% Using Options
NASDAQ · 5d ago
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), UnitedHealth (UNH) and Johnson & Johnson (JNJ)
TipRanks · 02/03 12:20
TransMedics: Italian NOP Program Reinforces Huge International Opportunity
Seeking Alpha · 02/03 12:15
These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More
Benzinga · 02/02 19:08
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC) and TransMedics Group (TMDX)
TipRanks · 02/02 16:20
Weekly Report: what happened at TMDX last week (0126-0130)?
Weekly Report · 02/02 09:54
Strata Critical Medical: Likely Valuation Re-Rating After Q4 Earnings (Upgrade)
Seeking Alpha · 01/29 13:46
4 Stocks to Load Up on Before Earnings
NASDAQ · 01/29 11:20
Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX) and Steris (STE)
TipRanks · 01/26 10:50
Weekly Report: what happened at TMDX last week (0119-0123)?
Weekly Report · 01/26 09:54
Here's How Much You Would Have Made Owning TransMedics Group Stock In The Last 5 Years
Benzinga · 01/23 15:00
Analysts Offer Insights on Healthcare Companies: ImmunityBio (IBRX) and TransMedics Group (TMDX)
TipRanks · 01/23 11:50
More
Webull provides a variety of real-time TMDX stock news. You can receive the latest news about Transmedics Group through multiple platforms. This information may help you make smarter investment decisions.
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.